Ha habido 50 transacciones internas recientes registradas para Adial Pharmaceuticals, Inc. (ADIL), incluyendo 46 compras y 1 venta. El total de compras internas fue valorado en $2.6M y el total de ventas internas en RSU Award.
Internos destacados con actividad reciente incluyen Claiborne Cary J, Goodman Tony, Anderson J. Kermit. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — ADIL
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2025-05-29 |
Claiborne Cary J |
Chief Executive Officer |
Concesión de RSU |
138,000 |
$0.69 |
$94.94K |
138,000 |
| 2025-05-29 |
Goodman Tony |
Chief Operating Officer |
Concesión de RSU |
94,000 |
$0.69 |
$64.67K |
94,000 |
| 2025-05-29 |
Anderson J. Kermit |
Director |
Concesión de RSU |
28,000 |
$0.69 |
$19.26K |
28,000 |
| 2025-05-29 |
Schuyler Kevin |
Director |
Concesión de RSU |
28,000 |
$0.69 |
$19.26K |
28,000 |
| 2025-05-29 |
Gilliland Robertson H. |
Director |
Concesión de RSU |
28,000 |
$0.69 |
$19.26K |
28,000 |
| 2025-05-29 |
Newman James W. Jr. |
Director |
Concesión de RSU |
28,000 |
$0.69 |
$19.26K |
28,000 |
| 2025-05-29 |
Shah Vinay |
Chief Financial Officer |
Concesión de RSU |
9,000 |
$0.69 |
$6.19K |
9,000 |
| 2024-12-05 |
Claiborne Cary J |
Chief Executive Officer |
Concesión de RSU |
350,000 |
$1.15 |
$402.5K |
350,000 |
| 2024-11-16 |
Shah Vinay |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-11-16 |
Shah Vinay |
Chief Financial Officer |
Concesión de RSU |
40,000 |
$1.06 |
$42.4K |
40,000 |
| 2024-03-25 |
Claiborne Cary J |
Chief Executive Officer |
Concesión de RSU |
60,000 |
$1.35 |
$81K |
60,000 |
| 2024-03-25 |
Goodman Tony |
Chief Operating Officer |
Concesión de RSU |
42,000 |
$1.35 |
$56.7K |
42,000 |
| 2024-03-25 |
Anderson J. Kermit |
Director |
Concesión de RSU |
12,000 |
$1.35 |
$16.2K |
12,000 |
| 2024-03-25 |
Truluck Joseph |
Chief Financial Officer |
Concesión de RSU |
25,000 |
$1.35 |
$33.75K |
25,000 |
| 2024-03-25 |
Schuyler Kevin |
Director |
Concesión de RSU |
12,000 |
$1.35 |
$16.2K |
12,000 |
| 2024-03-25 |
Gilliland Robertson H. |
Director |
Concesión de RSU |
12,000 |
$1.35 |
$16.2K |
12,000 |
| 2024-03-25 |
Newman James W. Jr. |
Director |
Concesión de RSU |
12,000 |
$1.35 |
$16.2K |
12,000 |
| 2023-09-29 |
Schuyler Kevin |
Director |
Compra Informativa |
700 |
$2.74 |
$1.92K |
700 |
| 2023-05-23 |
Claiborne Cary J |
Chief Executive Officer |
Concesión de RSU |
300,000 |
$0.30 |
$90.75K |
300,000 |
| 2023-05-23 |
Goodman Tony |
Director |
Concesión de RSU |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Anderson J. Kermit |
Director |
Concesión de RSU |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Stilley William B. Iii |
Director |
Concesión de RSU |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Truluck Joseph |
Chief Financial Officer |
Concesión de RSU |
125,000 |
$0.30 |
$37.81K |
125,000 |
| 2023-05-23 |
Schuyler Kevin |
Director |
Concesión de RSU |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Gilliland Robertson H. |
Director |
Concesión de RSU |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Newman James W. Jr. |
Director |
Concesión de RSU |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Johnson Bankole A. |
Director |
Concesión de RSU |
40,000 |
$0.30 |
$12.1K |
40,000 |
| 2022-12-30 |
Stilley William B. Iii |
Director |
Devolución de Acciones |
166,667 |
- |
- |
1,020,979 |
| 2022-09-20 |
Claiborne Cary J |
Chief Executive Officer |
Concesión de RSU |
75,000 |
$0.42 |
$31.52K |
1,100,000 |
| 2022-09-19 |
Claiborne Cary J |
Chief Executive Officer |
Concesión de RSU |
25,000 |
$0.43 |
$10.74K |
1,025,000 |
| 2022-08-22 |
Stilley William B. Iii |
Director |
Concesión de RSU |
100,000 |
$0.56 |
$55.5K |
100,000 |
| 2022-08-18 |
Claiborne Cary J |
Chief Executive Officer |
Concesión de RSU |
1,000,000 |
- |
- |
1,000,000 |
| 2022-06-27 |
Goodman Tony |
Director |
Concesión de RSU |
25,000 |
- |
- |
25,000 |
| 2022-02-23 |
Claiborne Cary J |
Chief Operating Officer |
Concesión de RSU |
6,667 |
$2.00 |
$13.33K |
6,667 |
| 2022-02-23 |
Goodman Tony |
Director |
Concesión de RSU |
40,000 |
$2.00 |
$80K |
40,000 |
| 2022-02-23 |
Anderson J. Kermit |
Director |
Concesión de RSU |
40,000 |
$2.00 |
$80K |
40,000 |
| 2022-02-23 |
Stilley William B. Iii |
Chief Executive Officer |
Concesión de RSU |
250,000 |
- |
- |
1,187,646 |
| 2022-02-23 |
Truluck Joseph |
Chief Financial Officer |
Concesión de RSU |
100,000 |
$2.00 |
$200K |
100,000 |
| 2022-02-23 |
Schuyler Kevin |
Director |
Concesión de RSU |
40,000 |
$2.00 |
$80K |
40,000 |
| 2022-02-23 |
Johnson Bankole A. |
Chief Medical Officer |
Concesión de RSU |
35,000 |
$2.00 |
$70K |
35,000 |
| 2022-02-23 |
Gilliland Robertson H. |
Director |
Concesión de RSU |
40,000 |
$2.00 |
$80K |
40,000 |
| 2022-02-23 |
Newman James W. Jr. |
Director |
Concesión de RSU |
40,000 |
$2.00 |
$80K |
40,000 |
| 2021-12-30 |
Newman James W. Jr. |
Director |
Compra Informativa |
10,000 |
$2.66 |
$26.6K |
20,000 |
| 2021-12-23 |
Schuyler Kevin |
10 Percent Owner |
Donación (Otorgada) |
90,000 |
$6.25 |
$562.5K |
- |
| 2021-12-07 |
Claiborne Cary J |
Chief Operating Officer |
Concesión de RSU |
130,000 |
$2.77 |
$360.1K |
130,000 |
| 2021-11-30 |
Stilley William B. Iii |
10 Percent Owner, Officer: Chief Executive Officer |
Compra Informativa |
10,600 |
$2.75 |
$29.18K |
937,646 |
| 2021-11-29 |
Stilley William B. Iii |
10 Percent Owner, Officer: Chief Executive Officer |
Compra Informativa |
10,000 |
$2.59 |
$25.89K |
927,046 |
| 2021-11-26 |
Newman James W. Jr. |
Director |
Compra Informativa |
10,000 |
$2.85 |
$28.5K |
34,475 |
| 2021-11-02 |
Claiborne Cary J |
Director |
Desconocido |
- |
- |
- |
- |
| 2021-11-02 |
Claiborne Cary J |
Director |
Concesión de RSU |
60,000 |
$3.15 |
$189K |
60,000 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
